Genetic engineering now allows biological synthesis and large-scale production of several proteins with therapeutic potential. The principal challenge in this sphere is to identify new, medically and commercially significant targets — the province of cell biologists, physiologists and biochemists. In the future, genetic engineering will surely provide invaluable tools for the study of the molecular basis of cellular control and pathophysiology, which will permit biochemists and medicinal chemists to design novel medicines.
This is a preview of subscription content, log in via an institution to check access.
References
Gruber, K. A., Whitaker, J. M. & Buckalew, V. M. Nature 287, 743–745, (1980).
Scott, G. M. et al. Lancet ii, 186–188, 1982.
Milstein, C. Scient. Am. 243(4), 66–74 (1980).
Cuatrecasas, P. in Advances in Ezymology (ed. Meister, A.) 29–89 (Wiley, New York, 1972.
Bull. Wld Hlth Org. 61, 81–92 (1983).
Arnon, R. A. Rev. Microbiol, 34, 593–618 (1980).
Bittle, J. L. et al. Nature 298, 30 (1982).
Audibert, F et al. Nature 289, 593 (1981).
Ferreira, S. H. Br. J. Pharmac. 24, 163 (1965).
Cushman, D. W. et al. in Enzyme Inhibitors as Drugs (ed. Sandier, M.) 231–247 (Macmillan, London, (1980).
Beddell, C. R. et al. Proc. R. Soc. B198, 249–265 (1977).
Haggin, J. Chem. Engng News 9 May, 7–20 (1983).
Elion, G. B. Am. J. Med. 73, 7–13 (1982).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Vane, J., Cuatrecasas, P. Genetic engineering and pharmaceuticals. Nature 312, 303–305 (1984). https://doi.org/10.1038/312303a0
Issue Date:
DOI: https://doi.org/10.1038/312303a0
- Springer Nature Limited
This article is cited by
-
Patents and literature
Applied Biochemistry and Biotechnology (1986)